Cubist Systematic Strategies, LLC Gilead Sciences, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$66.59 - $83.99 $1.19 Million - $1.5 Million
-17,800 Reduced 71.49%
7,100 $595,000
Q2 2024

Aug 14, 2024
SELL
$63.15 - $72.88 $1.85 Million - $2.14 Million
-29,300 Reduced 54.06%
24,900 $1.71 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $293,478 - $357,889
-4,100 Reduced 7.03%
54,200 $3.97 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $1.68 Million - $1.9 Million
-22,900 Reduced 28.2%
58,300 $4.72 Million
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $6.28 Million - $6.85 Million
-84,900 Reduced 51.11%
81,200 $6.09 Million
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $10.2 Million - $11.6 Million
-133,700 Reduced 44.6%
166,100 $12.8 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $7.2 Million - $8.2 Million
-93,100 Reduced 23.7%
299,800 $24.9 Million
Q4 2022

Feb 14, 2023
BUY
$62.32 - $89.47 $22.2 Million - $31.9 Million
357,000 Added 994.43%
392,900 $33.7 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $1.32 Million - $1.5 Million
-22,100 Reduced 38.1%
35,900 $2.22 Million
Q2 2022

Aug 15, 2022
BUY
$57.72 - $65.01 $3.35 Million - $3.77 Million
58,000 New
58,000 $3.59 Million

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email